Not provided
Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| 2025-A00672-47 | Other Identifier | ID-RCB number |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This is a multicenter, prospective study aimed at providing information on the psychological effects (including post-traumatic stress symptoms) of utero-vaginal brachytherapy in patients with cervical cancer using self-administered questionnaires. The study also aims to assess the persistence of these symptoms over time, up to 5 years after brachytherapy. The results could help identify patients at risk of post-traumatic stress in this context and develop appropriate psychological interventions to improve their psychological well-being during and after treatment.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Patient with cervical cancer with an indication for uterovaginal brachytherapy |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Prospective questionnaires | Other | Post-traumatic stress disorder Checklist version DSM-5 (PCL-5) and quality of life questionnaires |
|
| Measure | Description | Time Frame |
|---|---|---|
| Post-Traumatic Stress Disorder evaluation | Evaluation with post-traumatic stress disorder Checklist version DSM-5 (PCL-5) - questionnaire with a Cut off score ≥ 32 | at 2 months |
| Measure | Description | Time Frame |
|---|---|---|
| Anxiety and Depression | Hospital Anxiety and Depression scale | until 60 months |
| Quality of Life (general module) | Evaluated with EORTC QLQ-C30 questionnaire |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Patient with cervical cancer with an indication for High-dose rate (HDR) or pulse-dose rate (PDR) uterovaginal brachytherapy
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Valérie SARTORI | Contact | 368767223 | 33 | promotion-rc@icans.eu |
| Claire VIT | Contact | 388258529 | 33 | c.vit@icans.eu |
| Name | Affiliation | Role |
|---|---|---|
| George NOEL, MD, PhD | ICANS, CPS | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Groupement Hospitalier Sud - Hopital Lyon Sud | Recruiting | Pierre-Bénite | 69495 | France |
Not provided
| ID | Term |
|---|---|
| D002583 | Uterine Cervical Neoplasms |
| D013313 | Stress Disorders, Post-Traumatic |
| ID | Term |
|---|---|
| D014594 | Uterine Neoplasms |
| D005833 | Genital Neoplasms, Female |
| D014565 | Urogenital Neoplasms |
| D009371 | Neoplasms by Site |
Not provided
Not provided
Not provided
Not provided
Not provided
| until 60 months |
| Quality of Life (cervical cancer module) | Evaluated with EORTC QLQ-CX24 questionnaire | until 60 months |
| Sexual Health evaluation | Sexual Health Questionnaire (EORTC SHQ-22) | until 60 months |
| ICANS | Recruiting | Strasbourg | 67033 | France |
|
| D009369 |
| Neoplasms |
| D002577 | Uterine Cervical Diseases |
| D014591 | Uterine Diseases |
| D005831 | Genital Diseases, Female |
| D052776 | Female Urogenital Diseases |
| D005261 | Female Urogenital Diseases and Pregnancy Complications |
| D000091642 | Urogenital Diseases |
| D000091662 | Genital Diseases |
| D040921 | Stress Disorders, Traumatic |
| D000068099 | Trauma and Stressor Related Disorders |
| D001523 | Mental Disorders |